DEC 24, 2015 12:51 PM PST

New Drug Combats Mold Disease

WRITTEN BY: Kerry Evans
People suffering from leukemia or lymphoma are particularly vulnerable to mold diseases such as aspergillosis and mucormycosis.  The drug voriconazole is often used to treat these infections, but causes serious side effects such as kidney and liver damage.  Recently, researchers at the University of California, Davis, confirmed that the drug isavuconazole is just as effective as voriconazole, while causing far fewer side effects.
 
Aspergillus causes serious infections in the immunocompromised.

According to study author George Thompson, “molds are ubiquitous in the environment, but they are generally no consequence for people with intact immune systems … however, for leukemia and lymphoma patients, and others with compromised immune systems, some molds can be 90% fatal”.  

Aspergillosis is caused by mold in the genus Aspergillus.  The mold spores enter the lungs where they can grow into a “fungus ball”.  In the immunocompromised, the spores make their way into the bloodstream where the mold can infect the heart and kidneys.  Mucormycosis, on the other hand, is a disease caused by mold from the order Mucorales where hyphae grow in and around blood vessels. These molds typically infect the sinuses and brain, but can also spread to the gastrointestinal tract.  

In the UC Davis study, 35% of infections responded to isavuconazole, and 36.4% responded to voriconazole.  However, only 42.4% of patients taking isavuconazole reported side effects, compared to 59.8% taking voriconazole.  

Since isavuconazole can treat mold disease with fewer side effects, cancer patients aren’t forced to choose between treating the mold or treating the cancer.  According to Thompson, “when these patients get a bad infection, they still need more chemotherapy … it’s one thing to cure the infection but they end up dying of leukemia.  Now that there’s a drug with fewer side effects, patients can hopefully continue their chemotherapy with fewer interruptions”.

Sources: Futurity, Wikipedia
 
About the Author
  • Kerry received a doctorate in microbiology from the University of Arkansas for Medical Sciences.
You May Also Like
OCT 20, 2019
Microbiology
OCT 20, 2019
The Therapeutic Potential of Bacteriophages
There are vast numbers of viruses in our world, and some of them, called bacteriophages, only infect bacteria....
OCT 20, 2019
Genetics & Genomics
OCT 20, 2019
Does Diet Shape Our Microbiome More than Genetics?
Recent findings from mouse studies have concluded that genetics may have a more important role than environmental factors in the composition of the microbi...
OCT 20, 2019
Microbiology
OCT 20, 2019
New Strain of Strep Linked to Rise in Infections
Streptococci are a group of Gram-positive microbes that include pathogens that can cause mild and serious infections....
OCT 20, 2019
Cell & Molecular Biology
OCT 20, 2019
Researchers Prevent the Common Cold in Human Cells and Mice
Colds are famous for being incurable, but researchers may have found a way to stop them....
OCT 20, 2019
Cell & Molecular Biology
OCT 20, 2019
RNA Polymerases Can Signal to One Another Over Long Genomic Distances
Scientists have taken a close look at transcription in the Escherichia coli bacterium at the level of a single molecule....
OCT 20, 2019
Microbiology
OCT 20, 2019
Scientists Capture Video of a Virus Forming
In a first, scientists have captured video of individual viruses as they form, illustrating viral assembly....
Loading Comments...